WARRINGTON, Pa., May 1, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (NasdaqGM:DSCO - News) today announces that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its U.S. Patent Application Number 11/326,885 titled ``Surfactant Treatment Regiment.'' The Notice of Allowance is the USPTO's official communication that the examination of the patent application has been successfully completed and that a patent will be issued. Once issued, the patent will provide broad coverage for methods of using pulmonary surfactant to treat infants at risk of developing bronchopulmonary dysplasia (BPD).
